Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis

Haiping Zhang1 Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing211166, Jiangsu, People’s Republic of China

Jiani Wu1 Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing211166, Jiangsu, People’s Republic of China

Zhuolin Zhang2 Department of Clinical Pharmacy, School of Pharmacy, Nanjing Medical University, Nanjing211166, Jiangsu, People’s Republic of China

Haisheng Qian3 Department of Internal Medicine, The First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu210029, People’s Republic of China

Yifan Wang1 Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing211166, Jiangsu, People’s Republic of China

Miaomiao Yang1 Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing211166, Jiangsu, People’s Republic of China

Yinchu Cheng4 Department of Pharmacy, Peking University Third Hospital, Beijing100191, People’s Republic of China

Shaowen Tang1 Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing211166, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]

show all

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date